
Nab-Paclitaxel Monotherapy Shows Promise for Previously Treated, Advanced NSCLC
Author(s) -
Catlin Nalley
Publication year - 2017
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527180.72655.02
Subject(s) - docetaxel , medicine , paclitaxel , nivolumab , pembrolizumab , atezolizumab , oncology , durvalumab , lung cancer , chemotherapy , carboplatin , non small cell lung cancer (nsclc) , cancer , immunotherapy , cisplatin , a549 cell